[{"ATTACHMENTNAME":"B5E17E38_32ED_424A_9786_CF991F61235A_153000.pdf","NEWS_DT":"2016-11-18T15:30:02","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Natco Pharma Ltd has submitted to BSE a copy of the transcript of the Conference Call held on November 15, 2016.","SCRIP_CD":524816,"AGENDA_ID":1,"NEWSSUB":"Transcript of Conference Call"},{"ATTACHMENTNAME":"9274967b-6fbd-4387-a188-459d24a71eb9.pdf","NEWS_DT":"2022-11-11T15:22:30.79","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Q2 FY2023 Earnings call Audio Transcript","SCRIP_CD":524816,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"25b58ba7-48ac-4df7-9b6e-c83ac4a01c76.pdf","NEWS_DT":"2022-08-17T17:17:20.753","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Earnings Call Transcript for the Q1 FY22-23","SCRIP_CD":524816,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"b38c135c-32ae-42bb-bc9f-67b740d71d31.pdf","NEWS_DT":"2022-08-10T15:56:29.9","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"weblink for the Audio Transcript for the  Earnings call  held on 10th August, 2022","SCRIP_CD":524816,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"59238945-3195-4715-8cff-15f626b21d25.pdf","NEWS_DT":"2022-06-04T09:38:19.023","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Q4 FY 2022 Earnings Call Transcript","SCRIP_CD":524816,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"5e14d5b2-6ab8-40d3-9436-393d6532f034.pdf","NEWS_DT":"2022-05-31T16:25:38.427","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Recording of Analysts/Institutional Investor Meet/Con. Call held on 31st May, 2022","SCRIP_CD":524816,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]